DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Current Program Funding Opportunities


FY19 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Therapeutic Development Award Program Announcement
Application Instructions
November 20, 2019
  • Maximum funding of $1.0 million for direct costs (plus indirect costs); $1.25 million for direct costs (plus indirect costs) for applications including the Therapeutically Relevant Marker Option.
  • Maximum period of performance is 2 years.
Pre-Application: March 22, 2019

Pre-Application is required; Full application submission is by invitation only.

Application: July 25, 2019
Therapeutic Idea Award Program Announcement
Application Instructions
November 20, 2019
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application: March 22, 2019

Pre-Application is required; Full application submission is by invitation only.

Application: July 25, 2019




FY19 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 Program Announcement
Application Instructions
January 22, 2019 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 1 with Partnering PI Option:
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2:
  • Maximum funding of $1M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2 with Partnering PI Option:
  • Maximum funding of $ 1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
Funding Level 2 – Population Science and Prevention Studies:
  • Maximum funding of $ 1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:
  • Maximum funding of $ 2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019
Breakthrough Award Level 3 Program Announcement
Application Instructions
January 22, 2019 Funding Level 3:
  • Maximum funding of $3M in direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Funding Level 3 with Partnering PI Option:
  • Maximum funding of $4M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 12, 2019

Invited Application:
June 13, 2019
Breakthrough Award Level 4 Program Announcement
Application Instructions
January 22, 2019 Funding Level 4 and Funding Level 4 with Partnering PI Option:
  • Maximum funding of $10M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 12, 2019

Invited Application:
June 13, 2019
Era of Hope Scholar Award Program Announcement
Application Instructions
January 22, 2019
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019

Confidential Letters of Recommendation Submission Deadline: April 2, 2019
Innovator Award Program Announcement
Application Instructions
January 22, 2019
  • Maximum funding of $5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 12, 2019

Invited Application: June 13, 2019

Confidential Letters of Recommendation Submission Deadline: June 18, 2019
Distinguished Investigator Award Program Announcement
Application Instructions
January 22, 2019
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 12, 2019

Invited Application: June 13, 2019

Confidential Letters of Recommendation Submission Deadline: June 18, 2019
Breakthrough Fellowship Award Program Announcement
Application Instructions
January 22, 2019
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Letter of Intent): March 14, 2019

Application: March 28, 2019

Confidential Letters of Recommendation Submission Deadline: April 2, 2019


FY19 Defense Medical Research and Development Program (DMRDP) Combat Casualty Care Research Program (JPC-6)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
FY19 Multi-Domain Lifesaving Trauma Innovations (MuLTI) Award Program Announcement
Application Instructions
January 18, 2019 For studies involving prospective accrual of human subjects and clinical trials::
  • Maximum funding of $2.5 million (M) for total costs.
  • The maximum period of performance is 3 years.
For all other research:
  • Maximum funding of $1.0M for total costs.
  • The maximum period of performance is 3 years.
Pre-Application (Preproposal):
March 5, 2019

Inivted Application:
May 29, 2019


FY19 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Discovery Award Program Announcement
Application Instructions
January 15, 2019
  • Maximum funding of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years
Pre-Application (Letter of Intent): March 28, 2019

Application: April 11, 2019
Clinical Trial Award Program Announcement
Application Instructions
January 15, 2019
  • No maximum funding limit; requested funding must be justifiable and appropriate for the scope of work proposed; budget will be considered during pre-application screening and will be a scored full application criterion
  • Maximum period of performance is 4 years
Pre-Application (Preproposal): March 14, 2019

Application: July 2, 2019
Focused Program Award Program Announcement
Application Instructions
January 15, 2019
  • Maximum funding of $7.2 million for direct costs (plus indirect costs)
  • Maximum period of performance is 4 years
Pre-Application (Preproposal): March 14, 2019

Application: July 2, 2019
Investigator-Initiated Research Award Program Announcement
Application Instructions
January 15, 2019
  • Maximum funding of $1.2 million for direct costs (plus indirect costs); $1.5 million for direct costs (plus indirect costs) for applications including a Partnering PI Option
  • Maximum period of performance is 3 years
Pre-Application (Preproposal): March 14, 2019

Application: July 11, 2019
Technology/Therapeutic Development Award Program Announcement
Application Instructions
January 15, 2019
  • Maximum funding of $3 million for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years
Pre-Application (Preproposal): March 14, 2019

Application: July 11, 2019






FY19 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions
February 19, 2019
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019
Idea Development Award Program Announcement
Application Instructions
February 19, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019
Clinical Translational Research Award Program Announcement
Application Instructions
February 19, 2019
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): April 18, 2019

Application: May 9, 2019

Last updated Friday, February 15, 2019